| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/31/2003 | WO2003062831A1 Method for determining differences in molecular interactions and for screening a combinatorial library |
| 07/31/2003 | WO2003062830A2 Fibronectin variants and screening methods |
| 07/31/2003 | WO2003062829A2 Identifying chemotherapeutic compounds |
| 07/31/2003 | WO2003062828A2 Determining chemotherapeutic effectiveness |
| 07/31/2003 | WO2003062827A2 Fluorescent detection of proteins in polyacrylamide gels |
| 07/31/2003 | WO2003062826A2 Materials and methods for examining and treating nasopharyngeal carcinoma |
| 07/31/2003 | WO2003062825A1 DIAGNOSTIC TEST METHOD FOR DETECTION OF THE GM ALLOTYPE G2m(n) |
| 07/31/2003 | WO2003062824A1 Lateral flow quantitative assay method and strip and laser-induced fluoerescence detection device therefor |
| 07/31/2003 | WO2003062823A1 Chip and method for analyzing enzyme immunity |
| 07/31/2003 | WO2003062822A1 Conjugate for determining antigens by means of biosensors |
| 07/31/2003 | WO2003062821A1 Modulators of the clc-7 chloride channel and methods for their identification and use in the treatment and prevention of osteoporosis and related disease states |
| 07/31/2003 | WO2003062820A1 Method for detecting the biocompatibility of polymers |
| 07/31/2003 | WO2003062819A2 Water- soluble derivatives of lipophilic drugs |
| 07/31/2003 | WO2003062818A1 Method for the spectroscopic analysis of viscose constituents |
| 07/31/2003 | WO2003062817A2 Method of measuring the toxicity of a fluid on activated sludge bacteria |
| 07/31/2003 | WO2003062816A1 Method for analyzing impurities in carbon dioxide |
| 07/31/2003 | WO2003062812A1 Analyzer having temperature sensor |
| 07/31/2003 | WO2003062811A1 Detection of molecular probes fixed to an active zone of a sensor |
| 07/31/2003 | WO2003062803A2 Method for quantitative video-microscopy and associated system and computer software program product |
| 07/31/2003 | WO2003062798A1 Spectroscopic diagnostic methods and system |
| 07/31/2003 | WO2003062797A1 Method and device for preparing biological samples for analysis |
| 07/31/2003 | WO2003062793A2 Analysis device |
| 07/31/2003 | WO2003062792A2 Methods for determining drug responsiveness |
| 07/31/2003 | WO2003062791A2 Detection of single nucleotide polymorphisms using planar waveguides |
| 07/31/2003 | WO2003062790A2 Solid phases optimized for chemiluminescent detection |
| 07/31/2003 | WO2003062789A2 Methods for isolating and characterizing short-lived proteins and arrays derived therefrom |
| 07/31/2003 | WO2003062787A2 Bioassay and biomolecular identification, sorting, and collection methods using magnetic microspheres |
| 07/31/2003 | WO2003062786A2 Biosensor for small molecule analytes |
| 07/31/2003 | WO2003062785A2 Detection of bovine viral diarrhea virus in hair samples |
| 07/31/2003 | WO2003062784A2 Apparatus and methods for monitoring the status of a metabolically active cell |
| 07/31/2003 | WO2003062783A2 Light addressable electrochemical detection of duplex structures |
| 07/31/2003 | WO2003062618A1 Method for operating a gas turbine group |
| 07/31/2003 | WO2003062471A1 Model cell systems for screening of anti-hypertrophic therapeutics |
| 07/31/2003 | WO2003062468A2 Method for binding site identification using a multi-scale approach |
| 07/31/2003 | WO2003062462A2 Method for isolating nucleic acids and protein from a single sample |
| 07/31/2003 | WO2003062461A1 Fmdv leader peptidase assay |
| 07/31/2003 | WO2003062457A1 Tissue engineered cartilage for drug discovery |
| 07/31/2003 | WO2003062456A1 Fabrication method of multisensors chips for detecting analytes |
| 07/31/2003 | WO2003062451A2 Fluorogenic dyes |
| 07/31/2003 | WO2003062450A2 Probe correction for gene expression level detection |
| 07/31/2003 | WO2003062448A2 Sqv nucleic acids and polypeptides |
| 07/31/2003 | WO2003062446A2 Mrp9 and its use detecting and treating cancer |
| 07/31/2003 | WO2003062444A2 Array systems and methods |
| 07/31/2003 | WO2003062429A1 Novel serine protease |
| 07/31/2003 | WO2003062428A1 Genetic sequences having methyltransferase activity and uses therefor |
| 07/31/2003 | WO2003062427A1 Method of screening drug for improving insulin resistance |
| 07/31/2003 | WO2003062420A1 Molecular libraries |
| 07/31/2003 | WO2003062419A1 Methods for multiple parameter screening and evolution of cells to produce small molecules with multiple functionalities |
| 07/31/2003 | WO2003062418A1 Method and apparatus for detecting nucleic acid data |
| 07/31/2003 | WO2003062416A1 Method of screening preventive and remedy for arteriosclerosis |
| 07/31/2003 | WO2003062411A1 Tyrosine kinase inhibitors |
| 07/31/2003 | WO2003062402A2 Use of collections of binding sites for sample profiling and other applications |
| 07/31/2003 | WO2003062401A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 07/31/2003 | WO2003062395A2 Predictor sets for tyrosine kinase pathways |
| 07/31/2003 | WO2003062394A2 Methods and compositions for rna interference |
| 07/31/2003 | WO2003062390A2 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
| 07/31/2003 | WO2003062377A2 COMPLETE GENOME SEQUENCE OF SIVcpzTAN1 |
| 07/31/2003 | WO2003062369A2 Expansion of renewable stem cell populations |
| 07/31/2003 | WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR |
| 07/31/2003 | WO2003062275A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | WO2003062274A1 Novel proteins and dnas thereof |
| 07/31/2003 | WO2003062273A2 Modulator of the notch signalling pathway and use thereof in medical treatment |
| 07/31/2003 | WO2003062264A2 Functional ligand display |
| 07/31/2003 | WO2003062262A2 Modulation of heat-shock-protein-based immunotherapies |
| 07/31/2003 | WO2003061835A1 Apparatus for retaining magnetic particles within a flow-through cell |
| 07/31/2003 | WO2003061596A2 Methods and reagents for generating chimeric serum peptide carri ers |
| 07/31/2003 | WO2003061590A2 Peptide constructs for treating disease |
| 07/31/2003 | WO2003061586A2 High affinity sensor for biological pathogens |
| 07/31/2003 | WO2003061583A2 Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes |
| 07/31/2003 | WO2003061580A2 Alteration of rab38 function to modulate mammalian pigmentation |
| 07/31/2003 | WO2003061573A2 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo |
| 07/31/2003 | WO2003061569A2 High-density lipoprotein assay device and method |
| 07/31/2003 | WO2003061567A2 Selective s1p1/edg1 receptor agonists |
| 07/31/2003 | WO2003061564A2 Gene expression profiles in liver disease |
| 07/31/2003 | WO2003061563A2 Method of preparing delta-9 tetrahydrocannabinol |
| 07/31/2003 | WO2003061561A2 Epsilon immunoglobulin chain derived peptides for induction of anti-ige antibodies |
| 07/31/2003 | WO2003061479A1 Measurement of protein synthesis rates in humans and experimental systems by use of isotopically labeled water |
| 07/31/2003 | WO2003061462A1 Method and equipment for measuring vapour flux from surfaces |
| 07/31/2003 | WO2003061454A2 Automatically detecting cells having nuclear and cytoplasmic densitometric features associated with disease by optical imaging |
| 07/31/2003 | WO2003061453A2 Device and method for the identification of analytes in bodily fluids |
| 07/31/2003 | WO2003061452A2 Method and system for early detection of infectious diseases or symptoms of bioterrorism attacks |
| 07/31/2003 | WO2003061386A1 Wt1 antisense oligos for the inhibition of breast cancer |
| 07/31/2003 | WO2003046514A3 Particle-based ligand assay with extended dynamic range |
| 07/31/2003 | WO2003046148A8 Polypeptide quantitation |
| 07/31/2003 | WO2003046140A3 Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample |
| 07/31/2003 | WO2003046128A3 Method of determining volume dependent hypertension through protein reduction in phosphorylation or concentration and related apparatus |
| 07/31/2003 | WO2003044178A3 Hybrid oligonucleotide primers for amplification of dna and uses thereof |
| 07/31/2003 | WO2003037253A3 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 07/31/2003 | WO2003035679A3 Molecules |
| 07/31/2003 | WO2003034043A3 Molecularly imprinted polymer solution anion sensor |
| 07/31/2003 | WO2003033149A3 Systems and methods for performing multiple diagnostic tests |
| 07/31/2003 | WO2003031984A3 Method for analysing the sequence of polypeptides |
| 07/31/2003 | WO2003031571A3 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/31/2003 | WO2003029484A3 Antimicrobial methods and materials |
| 07/31/2003 | WO2003027246A3 Antagonists |
| 07/31/2003 | WO2003025576A3 Mass labels |
| 07/31/2003 | WO2003025140A3 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 07/31/2003 | WO2003024388A3 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma |
| 07/31/2003 | WO2003023364A3 A method and apparatus for the on-stream analysis of total sulfur and/or nitrogen in petroleum products |
| 07/31/2003 | WO2003020702A9 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain |